These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 7572319

  • 1. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
    Qi H, Li M, Wronski TJ.
    J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
    [Abstract] [Full Text] [Related]

  • 2. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M, Mosekilde L, Søgaard CH, Thomsen JS, Wronski TJ.
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [Abstract] [Full Text] [Related]

  • 3. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD, Wronski TJ.
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [Abstract] [Full Text] [Related]

  • 4. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ, Yen CF, Qi H, Dann LM.
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y, Jee WS, Chen Y, Gasser J, Ke HZ, Li XJ, Kimmel DB.
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB.
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats.
    Mosekilde L, Søgaard CH, McOsker JE, Wronski TJ.
    Bone; 1994 Oct; 15(4):401-8. PubMed ID: 7917578
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats.
    Li M, Liang H, Shen Y, Wronski TJ.
    Bone; 1999 Feb; 24(2):95-100. PubMed ID: 9951776
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [Abstract] [Full Text] [Related]

  • 15. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H, Shen V, Dempster DW, Lindsay R.
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [Abstract] [Full Text] [Related]

  • 16. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE.
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.
    Mosekilde L, Thomsen JS, McOsker JE.
    Bone; 1997 May; 20(5):429-37. PubMed ID: 9145240
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L, Orhii PB, Banu J, Kalu DN.
    Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.